CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukaemia

Swiss Medical Weekly

Volumn 138, Issue 1-2, 2008, Pages 12-17

  Taspinar, Mehmet ^a   Aydos, Sena Erdogan ^a   Comez, Omer ^a   Elhan, Atilla Halil ^a   Karabulut, Haiti Gurhan ^a   Sunguroglu, Asuman ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

CML; CYP1A1; GSTM1; GSTT1; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC MYELOID LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; STATISTICAL SIGNIFICANCE;

EID: 38849137365     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Guengerich F. Metabolic activation of carcinogens. Pharmacol Ther. 1992;54:17-61.
2. Nebert DW, McKinnon RA, Puga A. Human drug-metabolizing enzyme polymorphisms: effect on risk of toxicity and cancer. DNA Cell Biol. 1996;15:273-80.
3. Induski JA, Lutz W. Metabolic genotype in relation to individual susceptibility to environmental carcinogens. Int Arch Occup Environ Health. 2000;73:71-85.
4. Chang B, Zheng S, Isaacs S, Turner A, Hawkins GA, Wiley K, et al. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer. 2003;106:375-8.
5. Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 Polymorphisms, Tobacco Use, and the Risk of Head and Neck Cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:185-91.
6. Terry KL, Titus-Ernstoff L, Garner EO, Vitonis AF, Cramer DW. Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:187-90.
7. Abbas A, Delvinquière K, Mathilde L, et al. GSTM1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to oesophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol. 2004;10(23):3389-93.
8. Arvanitis D, Koumantakis G, Anastasia G, Matalliotakis I, et al. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril. 2003;79(suppl 1):702-9.
9. Hefler AL, Tempfer BC, Grimm C, Lebrecht A, et al. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian Women. Cancer. 2004;101:264-9.
10. Lu N, Wu B, Xia Y, Wang W, Gu A, et al. Polymorphisms in CYP1A1 gene are associated with male infertility in a Chinese population. Int J Androl. 2007;25:1-7.
11. Aktaş D, Hascicek M, Sozen S, Ozen H, Tuncbilek E. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet Cytogenet. 2004;154:81-5.
12. Aynacioglu AS, Cascorbi I, Mrozikiewicz P, Roots I. High frequency of CYP1A1 mutations in a Turkish population. Arch Toxicol. 1998;72:215-8.
13. Kvitko K, Nunes JC, Weimer TA, Salzano FM, Hutz MH. Cytochrome P4501A1 polymorphisms in South American Indians 2000;72(6):1039-43.
14. Caspar PA, Hutz MH, Salzano FM, Hill K, Hurtado MA, et al. Polymorphisms of CYP1A1, CYP2E1, GSTM1, GSTT1, and TP53 Genes in Amerindians. Am J Phys Anthropol. 2002; 119:249-56.
15. Sinnet D, Krajinovic M, Labuda D. Genetic Susceptibility to Acute Lymphoblastic Leukaemia. Leuk Lymphoma. 2000;38 (5-6):447-62.
16. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88(8):496-509.
17. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to Acute Lymphoblastic Leukaemia in Indian Children. Pediatr Blood Cancer. 2004;43:560-7.
18. Cai L, Yu S-Z, Zhang Z-F. Glutathione S-transferase M1, T1 genotypes and the risk gastric cancer: A case-control study. World J Gastroenterol. 2001;7(4):506-9.
19. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukaemia. Environ. Mol. Mutagen 2004;43:100-9.
20. Garte S, Taioli E, Crosti F, Sainati L, Barisone E, Luciani M, et al. Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukaemia. Leuk Res. 2000;24: 971-4.
21. Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J, et al. Polymorphisms in Genes Encoding Drugs and Xenobiotic Metabolizing Enzymes, DNA Repair Enzymes, and response to Treatment of Childhood Acute Lymphoblastic Leukaemia. Clin Cancer Res. 2002;8:802-10.
22. Goodman MT, Mcduffie K, Hernandez B, Bertram C, Wilkens L, Guo C, et al. CYP1A1, GSTM1, and GSTT1 Polymorphisms and the Risk of Cervical Squamous Intraepithelial Lesions in a Multiethnic Population. Gynecol Oncol 2001; 81:263-9.
23. Suzuki K, Matsui H, Nakazato H, Koike HI, Okugi H, Hasumi M, et al. Association of the genetic polymorphism in cytochrome P450 (CYP)1A1 with risk of familial prostate cancer in a Japanese population: a case-control study. Cancer Lett. 2003;195:177-83
24. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer lett. 2001;174: 35-44.
25. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, Sepulveda QL. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. The Prostate. 2003;57: 111-7.
26. Chan CE, Lam SY, Fu KH, Kwong YL. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancer: relationship with aberrant promotor methylatjon of the CDKN2A and RARB genes. Cancer Genet Cytogenet. 2005;162:10-20.
27. Dufour C, Svahn J, Bacigalupo A, Longoni D, Varotto S, Iori PA, et al. Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anaemia in Caucasian patients. Aplastic Anaemia. 2005;90(8):1027-31.
28. Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis. 2003;24(5):875-82.
29. Björk J, Albin M, Welinder H, Tinnerberg H, Mauritzson N, Kauppinen T, et al. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia? Occup Environ Med. 2001;58: 722-7.
30. Gahanei M, Vosoghi AA. An epidemiologic study to screen for Chronic Myelocytic Leukaemia in war victims exposed to mustard gas. Environ Health Perspect. 2002;110:519-21.
31. Redaelli A, Bell C, Casagrande J, Stephens J, Botteman M, Laskin B, Pashos C. Clinical and epidemiologic burden of chronic myelogenous leukaemia. Expert Rev Anticancer Ther. 2004:4(1):85-96.
32. Löffler H, Bergmann J, Hochhaus A, Hehlmann R, Kramer A, The German CML Study Group. Reduced risk for chronic myelogenous leukaemia in individuals with the cytochrome P-450 gene polymorphism CYP1A1*2A. Blood 2001;98(13): 3874.
33. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1982.
34. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnet D. Susceptibility to Childhood Acute Lymphoblastic Leukaemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 Genetic Polymorphisms. Blood. 1999;5:1496-501.
35. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to Acute Leukemias. Am J Hematol. 2006;81: 162-70.
36. Gallegos-Arreola MP, Batista-Gonzáles CM, Delgado-Lamas JL, Figuera LE, Puebla-Pérez AM, Arnaud-López L, et al. Cytochrome P4501A1 polymorphism is associated with susceptibility to acute lymphoblastic leukaemia in adult Mexican patients. Blood Cells Mol Dis. 2004;33:326-9.
37. Clavel J, Bellec S, Rebouissou S, Ménégaux F, Feunteun J, Bonaïti-Pellié C, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee, and alcohol consumption during pregnancy. Eur J Cancer Prev. 2005;14:531-40.
38. Nagai F, Hiyoshi Y, Sugimachi K, Tamura HO. Cytochrome P450(CYP) Expression in Human Myeloblastic and Lymphoid Cell Lines. Biol Pharm Bull. 2002;25(3):383-5.
39. Oude Ophuis MB, van Lieshout EM, Roelofs HM, Peters WH, Manni JJ. Glutathione S-Transferase M1 and T1 and Cytochrome P4501A1 Polymorphisms in Relation to the Risk for Benign and Malignant Head and Neck Lesions. Cancer. 1998;1;82(5):936-43.
40. D'alò F, Voso MT, Guidi F, Massini G, Scardocci A, Sica S, et al. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukaemia. Hematologica. 2004;89:664-70.
41. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrow K. Genetic polymorphism of CYP genes, Alone or in Combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000;9:3-28.
42. Bajpai P, Tripathi AK, Agrawal D. Increased frequencies of Gutathione S-transferase (GSTM1 and GSTT1) null genotypes in Indian Patients with Chronic myeloid leukaemia. Leukaemia Research (2007), doi:10.1016/j.leukres.2007.02. 003.
43. Mondal BC, Paria N, Majumdar S, Chandra S, Mukhopadhyay A, Chaudhuri U, et al. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myleoid leukaemia. Eur J Cancer Prev. 2005;14:281-4.
44. Hishida A, Terakura S, Emi N, Yamamoto K, Murata M, et al. GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukaemia in Japanese. Asian Pac J Cancer Prev. 2005;6:251-5.
45. Lourenço JG, Ortega MM, Nascimento H, Teori TM, DeSouza AC, Costa FF, et al. Polymorphisms of Glutathione S-transferase mu1(GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur J Haemotol. 2005:75:530-1.
46. Lemos MC, Cabriata FJ, Silva HA, Vivan M, Plácido F, Regateiro FJ. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis. 1999;20(7):1225-9.
47. Arruda VR, Lima CSP, Grignoli CRE, de Melo MB, Lorand-Metze I, Alberto FL, et al. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematal. 2001;66:383-8.
48. Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis. 2000;21(1):43-7.
49. Ates NA, Tamer L, Ates C, Ercan B, Elipek T, Ocal K, et al. Glutathione S-Transferase M1, T1, P1 genotypes and risk for Development of colorectal cancer. Biochemical Genetics 2005;43:Nos.3/4:149-63.
50. Balta G, Yuksek N, Ozyurek E, Ertem U, Hisconmez G, Altay C. Characterization of MTHFR, GSTM1, GSTP1, and CYP1A1 Genotypes in Childhood Acute Leukaemia. Am J Hematol. 2003;73:154-60.
51. Ada AO, Suzen SH, Iscan M. Polymorphisms of cytochrome P450 1A1, glutathione S-transferase M1 and T1 in a Turkish population. Toxicol Lett. 2004;151:311-5.